• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病进展及针刺干预机制的研究进展

Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention.

作者信息

Shan Jinyi, Cao Ziyi, Yu Siming

机构信息

School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.

The First Clinical Medical College of Shaanxi, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, People's Republic of China.

出版信息

Int J Gen Med. 2024 Nov 27;17:5593-5609. doi: 10.2147/IJGM.S490049. eCollection 2024.

DOI:10.2147/IJGM.S490049
PMID:39619130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11608539/
Abstract

Diabetic kidney disease (DKD) is a form of kidney damage resulting from diabetes and represents a common, severe complication of the disease. Globally, DKD is a leading cause of chronic kidney disease (CKD). DKD occurs in both type 1 and type 2 diabetes patients, with early clinical manifestations including microalbuminuria and hypertension. As the condition progresses, symptoms such as massive proteinuria, hypoalbuminemia, and severe edema may appear. The key to treating DKD lies in controlling blood glucose and blood pressure, reducing proteinuria, and slowing the deterioration of kidney function. Acupuncture, a traditional Chinese medicine treatment, has shown some therapeutic effects on DKD through mechanisms such as regulating blood glucose, improving renal blood flow and microcirculation, antioxidation and anti-inflammation, and modulating gut microbiota.

摘要

糖尿病肾病(DKD)是由糖尿病导致的一种肾脏损害形式,是该疾病常见且严重的并发症。在全球范围内,DKD是慢性肾脏病(CKD)的主要病因。1型和2型糖尿病患者均可发生DKD,其早期临床表现包括微量白蛋白尿和高血压。随着病情进展,可能会出现大量蛋白尿、低白蛋白血症和严重水肿等症状。治疗DKD的关键在于控制血糖和血压、减少蛋白尿以及减缓肾功能恶化。针灸作为一种中医疗法,已通过调节血糖、改善肾血流和微循环、抗氧化和抗炎以及调节肠道微生物群等机制,对DKD显示出一定的治疗效果。

相似文献

1
Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention.糖尿病肾病进展及针刺干预机制的研究进展
Int J Gen Med. 2024 Nov 27;17:5593-5609. doi: 10.2147/IJGM.S490049. eCollection 2024.
2
Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment.糖尿病肾病治疗中中医药研究进展。
Pharm Biol. 2024 Dec;62(1):222-232. doi: 10.1080/13880209.2024.2314705. Epub 2024 Feb 15.
3
Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine.中西医结合评估糖尿病肾病患者的肾功能损害
Chin J Integr Med. 2023 Apr;29(4):308-315. doi: 10.1007/s11655-022-3520-0. Epub 2022 Jun 9.
4
Research progress of effective components of traditional Chinese medicine in intervening apoptosis of renal tubular epithelial cells in diabetic kidney disease.中药有效成分干预糖尿病肾病肾小管上皮细胞凋亡的研究进展
J Ethnopharmacol. 2025 May 28;348:119874. doi: 10.1016/j.jep.2025.119874. Epub 2025 Apr 23.
5
[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review].[糖尿病肾病的非经典临床类型与病理改变:综述]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1074-1079. doi: 10.12182/20231160102.
6
Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease.中药治疗糖尿病肾病的作用机制及临床应用
Front Pharmacol. 2022 Nov 3;13:1055296. doi: 10.3389/fphar.2022.1055296. eCollection 2022.
7
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.中医通过靶向肠道微生物群改善糖尿病肾病。
Pharm Biol. 2024 Dec;62(1):423-435. doi: 10.1080/13880209.2024.2351946. Epub 2024 May 17.
8
The Functional Role of microRNAs and mRNAs in Diabetic Kidney Disease: A Review.微小 RNA 和信使 RNA 在糖尿病肾病中的功能作用:综述。
Curr Diabetes Rev. 2024;20(6):e201023222412. doi: 10.2174/0115733998270983231009094216.
9
Clinical therapeutic strategies for early stage of diabetic kidney disease.糖尿病肾病早期的临床治疗策略
World J Diabetes. 2014 Jun 15;5(3):342-56. doi: 10.4239/wjd.v5.i3.342.
10
Diabetic Kidney Disease: Challenges, Advances, and Opportunities.糖尿病肾病:挑战、进展与机遇
Kidney Dis (Basel). 2020 Jul;6(4):215-225. doi: 10.1159/000506634. Epub 2020 Mar 31.

引用本文的文献

1
Facial edema after covid-19 ameliorated by acupuncture: A CARE-compliant case report.针刺改善新冠后面部水肿:一份符合 CARE 标准的病例报告。
Medicine (Baltimore). 2025 Jul 18;104(29):e43407. doi: 10.1097/MD.0000000000043407.

本文引用的文献

1
Comparison Between SGLT2 Inhibitors and Lactation: Implications for Cardiometabolic Health in Parous Women.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂与哺乳期的比较:对经产妇心脏代谢健康的影响
Metab Syndr Relat Disord. 2025 Mar;23(2):77-85. doi: 10.1089/met.2024.0182. Epub 2024 Oct 21.
2
Efficacy and Safety of Adding Empagliflozin to Liraglutide on Renal Function in Patients with Advanced-Stage Type 2 Diabetic Kidney Disease: A Randomized Controlled Trial.恩格列净联合利拉鲁肽对晚期2型糖尿病肾病患者肾功能的疗效及安全性:一项随机对照试验
Diabetes Metab Syndr Obes. 2024 Oct 14;17:3767-3781. doi: 10.2147/DMSO.S471535. eCollection 2024.
3
Factor analysis of traditional Chinese medicine symptoms for identification of syndrome patterns associated with idiopathic short stature in children.用于识别儿童特发性矮小相关证型的中医症状因子分析
Tzu Chi Med J. 2024 Jul 3;36(4):433-439. doi: 10.4103/tcmj.tcmj_277_23. eCollection 2024 Oct-Dec.
4
Identification of crucial genes and possible molecular pathways associated with active vitamin D intervention in diabetic kidney disease.鉴定与糖尿病肾病中活性维生素D干预相关的关键基因和可能的分子途径。
Heliyon. 2024 Sep 25;10(19):e38334. doi: 10.1016/j.heliyon.2024.e38334. eCollection 2024 Oct 15.
5
Regulatory role of electroacupuncture on satellite glial cell activity in the colon and dorsal root ganglion of rats with irritable bowel syndrome.电针对肠易激综合征大鼠结肠和背根神经节卫星胶质细胞活性的调节作用。
J Tradit Chin Med. 2024 Oct;44(5):981-990. doi: 10.19852/j.cnki.jtcm.2024.05.005.
6
Novel Insights into Diabetic Kidney Disease.糖尿病肾病的新见解。
Int J Mol Sci. 2024 Sep 23;25(18):10222. doi: 10.3390/ijms251810222.
7
Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities.探讨醛糖还原酶抑制剂作为与糖尿病相关残疾的有前途的治疗靶点。
Int J Biol Macromol. 2024 Nov;280(Pt 2):135761. doi: 10.1016/j.ijbiomac.2024.135761. Epub 2024 Sep 19.
8
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease.即使在正常范围内,血红蛋白水平较低也与糖尿病肾病有关。
Diabetes Metab. 2024 Nov;50(6):101580. doi: 10.1016/j.diabet.2024.101580. Epub 2024 Sep 18.
9
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan-A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform.非奈利酮在日本慢性肾脏病合并2型糖尿病患者中的早期临床经验——来自FOUNTAIN(非奈利酮多数据库证据生成网络)平台的多队列研究
J Clin Med. 2024 Aug 28;13(17):5107. doi: 10.3390/jcm13175107.
10
Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study.老年 2 型糖尿病患者骨转换标志物与肾脏疾病的关系:一项横断面研究。
BMC Endocr Disord. 2024 Sep 6;24(1):179. doi: 10.1186/s12902-024-01698-y.